The largest database of trusted experimental protocols

58 protocols using decitabine

1

Epigenetic Modulation of Colorectal Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CRC cell lines (LS174T, T84, LS180, HCT15, HT29, SW620, COLO205, HCT116, COLO320, LoVo, CaCo2) were obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA) and grown in media with supplements as described in Additional file 1: Table S2 under humidified atmosphere of 5% CO2.
Treatment with DNA methyltransferase inhibitor (DNMTi): 3.5 × 104 COLO205 or SW620 cells were seeded in six-well plates and treated with 0.5% DMSO, 1.25 μM, 2.5 μM, 5 μM, and 10 μM of decitabine (Stock 50 mM in DMSO, Cat.#S1200, Selleckchem, Houston, TX, USA) for 48 h.
Treatment with histone deacetylase inhibitors (HDACi): 3.5 × 104 COLO205 or SW620 cells were seeded in six-well plates and treated with 0.01% DMSO, 50 nM trichostatin A (Stock 5 mM in DMSO, Cat.# T8552, Sigma-Aldrich, St. Louis, MO, USA) and 20 nM LMK-235 (Stock 10 mM in DMSO, Cat.# S7569, Selleckchem) alone or in combination with 2.5 μM, 5 μM, and 10 μM of decitabine for 48 h.
3.5 × 104 HT29, SW620, LS174T, and LoVo cells were seeded in six-well plates and treated with 8 × 10−3 DMSO, 5 nM, 10 nM, 20 nM, 40 nM, and 80 nM of LMK-235 for 48 h.
+ Open protocol
+ Expand
2

Cell line maintenance and treatments

Check if the same lab product or an alternative is used in the 5 most similar protocols
NCI-H1975, NCI-H1650, NCI-HCC827, NCI-H1299, A549 and PC9 cell lines were purchased from the Type Culture Collection of the Chinese Academy of Sciences (Shanghai, China). They were maintained in RPMI-1640 medium (Gibco-Life Technologies, NY, USA) supplemented with 10% fetal bovine serum (Gibco-Life Technologies), 100 μg/mL streptomycin and 100 U/mL penicillin (Gibco-Life Technologies). Cells were cultured at 37°C with a humid atmosphere of 5% CO2 and 95% air. Pemetrexed, decitabine, and cycloheximide were obtained from Selleck Chemicals (Houston, TX, USA).
+ Open protocol
+ Expand
3

Demethylation Assay for HCC Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human HCC cell lines (Bel-7402, HepG2, Huh7, MHCC-97H, MHCC-97L, SMMC-7721, SNU-387, and SNU-449) and immortalized normal liver cell line LO2 were purchased from American Type Culture Collection and Cell Resource Center of Shanghai Institutes. HepG2, Huh7, MHCC-97H, MHCC-97L, and LO2 were cultured in DMEM medium (Gibco) supplemented with 10% FBS (BI). Bel-7402, SMMC-7721, SNU-387, and SNU-449 were cultured in RPMI1640 medium (Gibco) supplemented with 10% FBS (BI). For demethylation treatment, HCC cells were treated with 10μM decitabine (Selleck, S1200) for 3 days and harvested for the following experiments.
+ Open protocol
+ Expand
4

Cytotoxicity Assay for Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
All cell lines were obtained from ATCC, where cell characterization was verified via polymorphic short tandem repeat (STR) profiling. Cells were cultured in RPMI1640 (Invitrogen) supplemented with 10% fetal bovine serum (Gibco), 1% GlutaMAX, and 1% sodium pyruvate solution. TGFβ was purchased from Cell Signaling Technology, and used to treat cells at a final concentration of 5 nM. Decitabine, thioguanine, osimertinib, erlotinib, and salinomycin were purchased from Selleck Chemicals. All inhibitors were reconstituted in DMSO (Sigma-Aldrich) at a stock concentration of 10 mM, and used to treat cancer cells at a final concentration of 4 μM. Lactate dehydrogenase (LDH) assays were performed using CytoTox 96 Non-Radioactive Cytotoxicity Assay Kit (Promega).
+ Open protocol
+ Expand
5

Decitabine, GO-203, and NAC Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Decitabine was purchased from Selleckchem (S1200). Genus Oncology LLC provided GO-203. N-acetyl cysteine (NAC) was purchased from Sigma.
+ Open protocol
+ Expand
6

Cell Cycle Analysis with DNMT Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell cycle analysis was performed with and without DNMT inhibitors (Decitabine (S1200) and 5-Azacytidine (S1782); Selleckchem) treatments as described before [33 (link)]. Briefly, MDA-MB-231 and BT-549 were treated with DNMT inhibitors at 2.0-μM final concentration in 6-well flat-bottom tissue culture plate. On day 3, cells were collected and fixed with 70% ice-cold ethanol and stored at 4° for overnight. Before staining, cells were washed with PBS twice and incubated in RNAse A (100 ug/ml) and propidium iodide (PI; 50 ug/ml) staining solution and then subjected to cell cycle analysis using BD LSRFortessa X-20 flow cytometer (BD Biosciences, CA, USA) at FL3 channel.
+ Open protocol
+ Expand
7

Decitabine and Vorinostat Treatment Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Decitabine and Vorinostat (code: s1200 and s1047, respectively) were purchased from SelleckChem, USA. DPN (code: 1494) was purchased from Tocris Bioscience, (UK). All other chemicals and materials were commercially available and of standard quality.
+ Open protocol
+ Expand
8

Glioma and Melanoma Cell Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two glioma cell lines (DBTRG05-MG and SNB19) and the melanoma M624 tumor cell line were maintained in RPMI 1640 l-glutamine (2 mM) with antibiotics (penicillin, 100 IU/mL, and streptomycin, 100 µg/mL) and 10% FBS (Life Technologies, Carlsbad, USA). The HLA-A2+ glioma tumor and melanoma cell lines were treated with decitabine (Selleckchem, Houston, USA) at 1 µM as described previously [27 (link)].
+ Open protocol
+ Expand
9

miRNA and Cell Proliferation Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
NB4 cells were pre-treated with Decitabine (Selleck Chemicals #S1200) or DMSO for control 24 hours before miR isolation or DNA isolation. NB4 cells or HL60 cells were pre-treated with Mubritinib (Selleck Chemicals #S2216) or DMSO for control 24 hours before miR isolation, MTT assay, and BrdU. NB4 cells were pre-treated with Mubritinib for 96 hours prior to Cd11b and Annexin-V analysis.
+ Open protocol
+ Expand
10

Epigenetic Modulation of Liver Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hep3B and HuH-7 cells were seeded in complete medium in 6-well plates at a concentration of 6 × 104 for treatments with 5-aza-2′-deoxycytidine, i.e., decitabine (Selleckchem, Cat. No. S1200, Batch No.09) or 15 × 104 for treatments with suberoylanilide hydroxamic acid (SAHA), i.e., vorinostat (Selleckchem, Cat. No. S1047, Batch No.11). Twenty-four hours later, the cells were treated with 5-aza-2′-deoxycytidine or SAHA at concentrations of 1, 2.5, 5, 7.5, and 10 μM or 1, 2, and 4 μM for 72 or 48 h, respectively. The culture medium was replaced daily, and dimethyl sulfoxide (DMSO) was used as vehicle control. Cells were subsequently collected for RNA extraction.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!